ABEV Ambev posts narrow Q4 2025 earnings beat shares fall 204 percent on muted investor sentiment ALIS Calisa CEO lays out 2024 regional expansion priorities alongside latest quarterly earnings release Sangamo Therapeutics SGMO Stock Momentum Analysis Sangamo Therapeutics posts 797 downside EPS miss